Patent · US Expired

Diphenylazetidinone derivatives for treating disorders of the lipid metabolism

US7470678B2 · kind B2 · utility

6Cited by
13References
37Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 1, 2003
Grant dateDec 30, 2008
Priority date
Expiry dateAug 24, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D205/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I): (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.